| 1 |
Nakanishi K, Yoshiyama M, Homma S. Patent foramen ovale and cryptogenic stroke [J]. Trends Cardiovasc Med, 2017, 27(8): 575-581.
|
| 2 |
Meissner I, Khandheria BK, Heit JA, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study [J]. J Am Coll Cardiol, 2006, 47(2): 440-445.
|
| 3 |
Hart RG, Catanese L, Perera KS, et al. Embolic stroke of undetermined source: A systematic review and clinical update [J]. Stroke, 2017, 48(4): 867-872.
|
| 4 |
Mattle HP, Meier B, Nedeltchev K. Prevention of stroke in patients with patent foramen ovale [J]. Int J Stroke, 2010, 5(2): 92-102.
|
| 5 |
赵欣, 邓燕. 卵圆孔未闭与不明原因脑卒中的研究进展 [J/CD]. 中华脑血管病杂志(电子版), 2020, 14(3): 163-166.
|
| 6 |
Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke [J]. Neurology, 2013, 81(7): 619-625.
|
| 7 |
张玉顺, 朱鲜阳, 孔祥清, 等. 卵圆孔未闭预防性封堵术中国专家共识 [J]. 中国循环杂志, 2017, 32(3): 209-214.
|
| 8 |
张国建, 南光贤. 卵圆孔未闭合并烟雾病患者2例报告 [J]. 吉林医学, 2017, 38(10): 1993-1995.
|
| 9 |
Fujimura M, Sonobe S, Nishijima Y, et al. Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene [J]. J Stroke, 2014, 16(2): 65-72.
|
| 10 |
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) [J]. Neurol Med Chir (Tokyo), 2012, 52(5): 245-266.
|
| 11 |
Kim BJ, Sohn H, Sun BJ, et al. Imaging characteristics of ischemic strokes related to patent foramen ovale [J]. Stroke. 2013, 44(12): 3350-3356.
|
| 12 |
Kim SK, Cho BK, Phi JH, et al. Pediatric moyamoya disease: An analysis of 410 consecutive cases [J]. Ann Neurol, 2010, 68(1): 92-101.
|
| 13 |
Kim JM, Lee SH, Roh JK. Changing ischaemic lesion patterns in adult moyamoya disease [J]. J Neurol Neurosurg Psychiatry, 2009, 80(1): 36-40.
|